| Segment reporting |
The Company’s operations are categorized into one industry segment, which is medical technology focused on magnetic resonance guided ablation procedures for the treatments to ablate the prostate gland, uterine fibroids, osteoid osteoma and nerves for palliative pain relief for patients with metastatic bone disease. The CODM, which is the Company’s Chief Executive Officer, regularly reviews the operating results of the Company on a consolidated basis as part of making decisions for allocating resources and evaluating performance. Further, the CODM is regularly provided with the consolidated expenses as noted on the consolidated statements of operations and comprehensive loss. The following tables represent total revenue by geographic area, based on the location of the reporting entity for the three months ended September 30, 2026 and 2025, respectively: | | | | | | | | | | | For the three months ended September 30, 2026 | | | Canada | | USA | | Germany | | Total | | | $ | | $ | | $ | | $ | Revenue | | | | | | | | | Recurring - non-capital | | 1,440 | | 2,052 | | 614 | | 4,106 | Capital equipment | | 3,441 | | 1,466 | | 817 | | 5,724 | | | 4,881 | | 3,518 | | 1,431 | | 9,830 |
| | | | | | | | | | | For the three months ended September 30, 2025 | | | Canada | | USA | | Germany | | Total | | | $ | | $ | | $ | | $ | Revenue | | | | | | | | | Recurring - non-capital | | 119 | | 3,779 | | 168 | | 4,066 | Capital equipment | | — | | 1,223 | | — | | 1,223 | | | 119 | | 5,002 | | 168 | | 5,289 |
| | | | | | | | | | | For the nine months ended September 30, 2026 | | | Canada | | USA | | Germany | | Total | | | $ | | $ | | $ | | $ | Revenue | | | | | | | | | Recurring - non-capital | | 3,054 | | 4,192 | | 946 | | 8,192 | Capital equipment | | 5,954 | | 2,687 | | 817 | | 9,458 | | | 9,008 | | 6,879 | | 1,763 | | 17,650 |
| | | | | | | | | | | For the nine months ended September 30, 2025 | | | Canada | | USA | | Germany | | Total | | | $ | | $ | | $ | | $ | Revenue | | | | | | | | | Recurring - non-capital | | 495 | | 6,399 | | 534 | | 7,428 | Capital equipment | | 570 | | 2,123 | | — | | 2,693 | | | 1,065 | | 8,522 | | 534 | | 10,121 |
The following tables represent other geographic information for the nine months ended September 30, 2026 and the year ended December 31, 2025: | | | | | | | | | | | | | | | For the period ended September 30, 2026 | | | Canada | | USA | | Germany | | China | | Finland | | Total | | | $ | | $ | | $ | | $ | | $ | | $ | Total assets | | 46,007 | | 7,257 | | 1,884 | | 100 | | 2,906 | | 58,154 | Intangible assets | | 115 | | — | | — | | — | | — | | 115 | Property and equipment | | — | | 285 | | — | | — | | 145 | | 430 | Right-of-use assets | | 2,687 | | — | | — | | — | | — | | 2,687 | Amortization of intangible assets | | 23 | | — | | — | | — | | — | | 23 | Depreciation of property and equipment | | 43 | | 272 | | — | | — | | 30 | | 345 |
| | | | | | | | | | | | | | | For the year ended December 31, 2025 | | | Canada | | USA | | Germany | | China | | Finland | | Total | | | $ | | $ | | $ | | $ | | $ | | $ | Total assets | | 63,046 | | 9,791 | | 1,243 | | 137 | | 3,258 | | 77,475 | Intangible assets | | 138 | | — | | — | | — | | — | | 138 | Property and equipment | | 41 | | 481 | | — | | — | | 176 | | 698 | Right-of-use assets | | 184 | | — | | — | | — | | — | | 184 | Amortization of intangible assets | | 187 | | — | | — | | — | | — | | 187 | Depreciation of property and equipment | | 51 | | 322 | | — | | — | | — | | 373 |
|